Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyrolytic hydrocarbon growth from cyclopentadiene.

The journal of physical chemistry. A·2010
Same author

In(III)-catalyzed tandem reaction of chromone-derived Morita-Baylis-Hillman alcohols with amines.

Organic & biomolecular chemistry·2010
Same author

Regression-based multi-trait QTL mapping using a structural equation model.

Statistical applications in genetics and molecular biology·2010
Same author

Elevated expression of APE1/Ref-1 and its regulation on IL-6 and IL-8 in bone marrow stromal cells of multiple myeloma.

Clinical lymphoma, myeloma & leukemia·2010
Same author

Accelerated aging of intervertebral discs in a mouse model of progeria.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2010
Same author

The synthesis of a multiblock osteotropic polyrotaxane by copper(I)-catalyzed huisgen 1,3-dipolar cycloaddition.

Macromolecular bioscience·2010

Related Experiment Video

Updated: May 13, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Tackling the Orexin Conundrum: An Optimized LC-MS/MS Method Demonstrates Accurate CSF Quantification and Absence in

Yan Cao1,2, Yimeng Zhang3, Jiaqi Han1,2

  • 1Department of Laboratory Medicine, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing 100026, China.

Analytical Chemistry
|May 12, 2026
PubMed
Summary
This summary is machine-generated.

Cerebrospinal fluid (CSF) orexin-A is the gold-standard biomarker for narcolepsy type 1. This study developed a new LC-MS/MS method, proving peripheral orexin levels are undetectable and refining narcolepsy diagnostics.

More Related Videos

Quantitative Metabolomics of Saccharomyces Cerevisiae Using Liquid Chromatography Coupled with Tandem Mass Spectrometry
07:25

Quantitative Metabolomics of Saccharomyces Cerevisiae Using Liquid Chromatography Coupled with Tandem Mass Spectrometry

Published on: January 5, 2021

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

Related Experiment Videos

Last Updated: May 13, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Quantitative Metabolomics of Saccharomyces Cerevisiae Using Liquid Chromatography Coupled with Tandem Mass Spectrometry
07:25

Quantitative Metabolomics of Saccharomyces Cerevisiae Using Liquid Chromatography Coupled with Tandem Mass Spectrometry

Published on: January 5, 2021

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

Area of Science:

  • Neuroscience
  • Analytical Chemistry
  • Biomarker Discovery

Background:

  • Cerebrospinal fluid (CSF) orexin-A is the gold-standard biomarker for narcolepsy type 1 (NT1).
  • Conventional radioimmunoassays (RIA) for orexin detection in peripheral blood suffer from cross-reactivity and overestimation.
  • Previous studies reported conflicting results regarding peripheral orexin levels due to analytical limitations.

Purpose of the Study:

  • To develop an ultrasensitive and highly specific liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for accurate orexin detection.
  • To re-evaluate the presence and levels of orexins in peripheral blood of narcolepsy patients.
  • To improve the diagnostic accuracy for narcolepsy type 2 (NT2) using the developed analytical method.

Main Methods:

  • Development of an ultrasensitive LC-MS/MS assay with a lower limit of quantification (LLOQ) of 0.1 pg/mL.
  • Incorporation of a one-step protein precipitation, acid-shielding, and cocktail-protection strategy to minimize artifacts.
  • Verification of the method using paired CSF and blood samples from narcolepsy patients and healthy controls.

Main Results:

  • Peripheral orexin-A and orexin-B levels were consistently below the detection limit (<0.1 pg/mL) in all subjects.
  • Reported peripheral orexin levels in previous studies using RIA were identified as analytical artifacts with up to 50-fold overestimation.
  • The LC-MS/MS method significantly improved diagnostic resolution for narcolepsy type 2 (AUC = 0.73, P < 0.05) compared to RIA (P = 0.297).

Conclusions:

  • CSF orexin-A remains the most reliable biomarker for narcolepsy type 1.
  • The developed LC-MS/MS method provides a high-specificity analytical framework for refined sleep disorder diagnostics.
  • Peripheral orexin detection is not a viable biomarker for narcolepsy diagnosis due to its absence in blood.